Preliminary clinical experience with robotic retroperitoneoscopic pancreatic surgery.

摘要: Retroperitoneoscopic surgery has shown advantages in urological surgery. However, its application pancreatic for neoplasm is rare. Robotic surgical system with magnified view and flexible instruments may provide a superior alternative to conventional laparoscopic retroperitoneoscopic We aimed evaluate the safety, feasibility, short-term outcomes series of patients treated by robotic Between March 2016 May 2016, four solitary neuroendocrine neoplasms were Prospective collected clinical data retrospectively analyzed. Three underwent distal pancreatectomy (one combined resection left adrenal adenoma), one patient enucleation. The mean operative time was 80 min (range 30–110 min). estimated blood loss insignificant. There no conversion open procedure. postoperative hospital stay 5.25 days 4–6 days). tumor size 1.375 cm 1.0–1.8 cm) diameter. All patients’ glucose level returned normal range within 1 week postoperatively. Two had biochemical leak. No subsequent treatment, recurrence occurred during 12-month follow-up period. This study preliminarily indicates that safe feasible dorsal portion pancreas selected patients, some potential straightforward access, simple fine manipulation, short time, fast recovery.